Moderna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance. -- Barrons.com

Dow Jones01-12

By Mackenzie Tatananni

Moderna gave investors a glimpse at its upcoming earnings report on Monday as it pre-announced revenue above the midpoint of its prior guidance range.

Presenting at the J.P. Morgan healthcare conference on Monday, Moderna said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company's third-quarter earnings call. For 2026, the company still expects revenue growth of up to 10%, and reiterated that it expects non-adjusted operating expenses to decline from $5 billion to $5.2 billion in 2025 to $4.9 billion in 2026.

Jefferies analysts posited Monday that "more reductions are needed to instill investor confidence in management's 2028 cash breakeven guidance." The company is slated to share its fourth-quarter and full-year results in February. Shares gained 2% in premarket trading, while futures tracking the S&P 500 were down 0.5%.

Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

January 12, 2026 08:51 ET (13:51 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602543637?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-12 21:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602543637","market":"fut","top_or_hot":-1,"title":"Moderna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance. -- Barrons.com","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Mackenzie Tatananni \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> gave investors a glimpse at its upcoming earnings report on Monday as it pre-announced revenue above the midpoint of its prior guidance range. \n</p>\n<p>\n  Presenting at the J.P. Morgan healthcare conference on Monday, Moderna said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company's third-quarter earnings call. For 2026, the company still expects revenue growth of up to 10%, and reiterated that it expects non-adjusted operating expenses to decline from $5 billion to $5.2 billion in 2025 to $4.9 billion in 2026. \n</p>\n<p>\n  Jefferies analysts posited Monday that \"more reductions are needed to instill investor confidence in management's 2028 cash breakeven guidance.\" The company is slated to share its fourth-quarter and full-year results in February. Shares gained 2% in premarket trading, while futures tracking the S&amp;P 500 were down 0.5%. \n</p>\n<p>\n  Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com \n</p>\n<p>\n   This content was created by Barron's, which is operated by Dow Jones &amp; Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 12, 2026 08:51 ET (13:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance. -- Barrons.com</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Stock Rises. Revenue in 2025 Will Be Higher Than Midpoint of Guidance. -- Barrons.com\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-12 21:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Mackenzie Tatananni \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> gave investors a glimpse at its upcoming earnings report on Monday as it pre-announced revenue above the midpoint of its prior guidance range. \n</p>\n<p>\n  Presenting at the J.P. Morgan healthcare conference on Monday, Moderna said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company's third-quarter earnings call. For 2026, the company still expects revenue growth of up to 10%, and reiterated that it expects non-adjusted operating expenses to decline from $5 billion to $5.2 billion in 2025 to $4.9 billion in 2026. \n</p>\n<p>\n  Jefferies analysts posited Monday that \"more reductions are needed to instill investor confidence in management's 2028 cash breakeven guidance.\" The company is slated to share its fourth-quarter and full-year results in February. Shares gained 2% in premarket trading, while futures tracking the S&amp;P 500 were down 0.5%. \n</p>\n<p>\n  Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com \n</p>\n<p>\n   This content was created by Barron's, which is operated by Dow Jones &amp; Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 12, 2026 08:51 ET (13:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4532","symbol_name":"文艺复兴科技持仓","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2602543637","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602543637","pubTimestamp":1768225860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Moderna gave investors a glimpse at its upcoming earnings report on Monday as it pre-announced revenue above the midpoint of its prior guidance range.Presenting at the J.P. Morgan healthcare conference on Monday, Moderna said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company's third-quarter earnings call. For 2026, the company still expects revenue growth of up to 10%, and reiterated that it expects non-adjusted operating expenses to decline from $5 billion to $5.2 billion in 2025 to $4.9 billion in 2026.Jefferies analysts posited Monday that \"more reductions are needed to instill investor confidence in management's 2028 cash breakeven guidance.\" The company is slated to share its fourth-quarter and full-year results in February. Shares gained 2% in premarket trading, while futures tracking the S&P 500 were down 0.5%.This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published in","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4532":"文艺复兴科技持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4534":"瑞士信贷持仓","MRNA":"Moderna, Inc.","BK4501":"段永平概念","BK4139":"生物科技","BK4551":"寇图资本持仓","BK4568":"美国抗疫概念","BK4588":"碎股","BK4548":"巴美列捷福持仓","BK4585":"ETF&股票定投概念"},"translate_title":"Moderna股价上涨。2025年收入将高于指导中点。——Barrons.com","themeId":"650860a889e83af5eb15ea72cc36cf6b","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"By Mackenzie Tatananni \n\n\nModerna gave investors a glimpse at its upcoming earnings report on Monday as it pre-announced revenue above the midpoint of its prior guidance range. \n\n\n  Presenting at the J.P. Morgan healthcare conference on Monday, Moderna said it expects 2025 revenue of roughly $1.9 billion, $100 million above the midpoint of the range communicated on the company's third-quarter earnings call. For 2026, the company still expects revenue growth of up to 10%, and reiterated that it expects non-adjusted operating expenses to decline from $5 billion to $5.2 billion in 2025 to $4.9 billion in 2026. \n\n\n  Jefferies analysts posited Monday that \"more reductions are needed to instill investor confidence in management's 2028 cash breakeven guidance.\" The company is slated to share its fourth-quarter and full-year results in February. Shares gained 2% in premarket trading, while futures tracking the S&P 500 were down 0.5%. \n\n\n  Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com \n\n\n   This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 12, 2026 08:51 ET (13:51 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602543637","isCrawlerRequest":true}